Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

GLUE

Monte Rosa Therapeutics, Inc.

CIK 0001826457 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$24.52
↑ 0.46 (1.91%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals, Options; Risks: Fundamentals

Key stats

Market Cap
$2.07B
P/E Ratio
-15.93
EPS
Not covered
Dividend Yield
Not covered
52W Position
94%
Beta
1.16

Valuation multiples

Fwd P/E
10.02
PEG
Not covered
P/B
3.97
P/S
48.23
EV/Revenue
44.50
ROE
-24.9%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 94%
$4.12$25.77

Latest Financials

2025-12-31 FY
Revenue
$123.67M
Net Income
-$38.63M
Total Assets
$448.66M
Free Cash Flow
-$27.50M

Recent news